Mar 25, 2024 · ZOFRAN should be avoided in these patients, since they may be more at risk for cardiac arrhythmias such as QT prolongation and Torsade de Pointes. ... For I.V. or I.M. …

Sep 24, 2024 · Detailed Ondansetron dosage information for adults and children. Includes dosages for Nausea/Vomiting, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - …

Feb 1, 2025 · Ondansetron injection is used to prevent nausea and vomiting caused by cancer medicines (chemotherapy or radiation), including high-dose cisplatin. This medicine is also …

Sep 24, 2024 · Ondansetron injection for the treatment of post-operative nausea and vomiting has been reported to cause drowsiness or sedation in 8% of patients vs. 7% of those using a …

Ondansetron injection is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin [see …

Ondansetron HCl is a white to off-white powder that is soluble in water and normal saline. Sterile Injection for Intravenous (I.V.) or Intramuscular (I.M.) Administration: Each 1 mL of aqueous …

Medscape - Nausea & vomiting dosing for Zofran (DSC) (ondansetron), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …

ZOFRAN Injection, 2 mg/mL is a clear, colorless, nonpyrogenic, sterile solution available as a 20-mL multidose vial. Storage And Handling. ZOFRAN Injection, 2 mg/mL, is supplied as follows: …

2 DOSAGE & ADMINISTRATION. 2.1 Prevention of Nausea and Vomiting Associated with Initial and Repeat Courses of Emetogenic Chemotherapy. Important Preparation Instructions • …

ZOFRAN is approved for patients aged 6 months and older. 1.2 Prevention of Postoperative Nausea and/or Vomiting ZOFRAN Injection is indicated for the prevention of postoperative …